Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults

Individuals with type 2 diabetes mellitus experience high rates of influenza virus infection and complications. We compared the magnitude and duration of serologic response to trivalent influenza vaccine in adults aged 50–80 with and without type 2 diabetes mellitus. Serologic response to influenza...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Influenza and other respiratory viruses 2022-05, Vol.16 (3), p.562-567
Hauptverfasser:	Spencer, Sarah, Chung, Jessie R., Belongia, Edward A., Sundaram, Maria, Meece, Jennifer, Coleman, Laura A., Zimmerman, Richard K., Nowalk, Mary Patricia, Moehling Geffel, Krissy, Ross, Ted, Carter, Chalise E., Shay, David, Levine, Min, Liepkalns, Justine, Kim, Jin Hyang, Sambhara, Suryaprakash, Thompson, Mark G., Flannery, Brendan
Format:	Artikel
Sprache:	eng
Schlagworte:	Adults Aged Aged, 80 and over Antibodies Antibodies, Viral Antigens Complications Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 Enrollments Guillain-Barre syndrome Hemagglutination Inhibition Tests Humans Immunogenicity Influenza Influenza A Virus, H3N2 Subtype Influenza Vaccines Influenza, Human - prevention & control Laboratories Memory Middle Aged Obesity Older people Original Regression analysis Respiratory diseases serologic response Serology Vaccination vaccine Vaccines Vaccines, Inactivated Viruses Vitamin D
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!